CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
MOXIdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05226104
NCT05226104N/ACompleted
CompareCT.gov

Investigating the Efficacy of a Fractionated 1927nm Laser for Diffuse Pigmentation and Actinic Changes

University of Texas Southwestern Medical Center·interventional·Posted Feb 7, 2022·Updated Aug 21, 2023

In Brief

A clinical study evaluating MOXI for Skin Pigment. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This is a single-site, non-randomized, non-controlled study at UT Southwestern Medical Center at Dallas in the Department of Plastic Surgery designed to follow up to 30 qualified and consenting subjects receiving a fractionated 1927 combination treatments for diffuse hyperpigmentation and/or melasma. Patients will receive treatment using f1927 devices and will be treated twice over the affected areas, once each month for a total of two months, followed by two follow-up visits at 1-month and 3-months post-treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Pigment
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedFeb 7, 2022
Enrollment StartMay 18, 2022
Primary CompletionSep 28, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.4 years ago

Interventions

MOXIdevice

Patients will receive treatment using f1927 devices and will be treated twice over the affected areas, once each month for a total of two months.